Akoya BioSciences
AKYA
AKYA was delisted on the 7th of July, 2025.
62 hedge funds and large institutions have $74.9M invested in Akoya BioSciences in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 32 increasing their positions, 12 reducing their positions, and 17 closing their positions.
2,371% more call options, than puts
Call options by funds: $173K | Put options by funds: $7K
167% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 12
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
1.26% less ownership
Funds ownership: 34.1% → 32.83% (-1.3%)
15% less funds holding
Funds holding: 73 → 62 (-11)
37% less capital invested
Capital invested by funds: $119M → $74.9M (-$43.8M)
65% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KLC
Kent Lake Capital
Reno,
Nevada
|
+$4.29M |
| 2 |
BlackRock
New York
|
+$1.47M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$572K |
| 4 |
Squarepoint
New York
|
+$505K |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$369K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$3.56M |
| 2 |
PVI
Pura Vida Investments
New York
|
-$2.67M |
| 3 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$2.04M |
| 4 |
FAM
Fred Alger Management
New York
|
-$1.94M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$690K |
AKYA Hedge Fund Activity: Q3 2023 in Review
62 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Akoya BioSciences (AKYA) for Q3 2023, worth a combined $74.9M — down 37% from $119M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of AKYA and 6 opened new positions — a net loss of 11 holders — while 12 trimmed existing stakes and 32 added.
The largest buyer was Kent Lake Capital, opening a new position worth an estimated $4.29M. The largest seller was Granahan Investment Management, exiting entirely with an estimated $3.56M sold.
- 62 institutional investors held Akoya BioSciences (AKYA) as of Q3 2023, down from 73 in Q2 2023.
- Funds reported $74.9M of Akoya BioSciences stock for Q3 2023, down 37% quarter-over-quarter.
- 6 funds opened new Akoya BioSciences positions in Q3 2023 and 17 closed out, a net change of -11 holders.
- The largest Akoya BioSciences buyer in Q3 2023 was Kent Lake Capital, an estimated $4.29M added.
- The largest Akoya BioSciences seller in Q3 2023 was Granahan Investment Management, an estimated $3.56M sold.
Based on aggregated 13F filings for Q3 2023.